Chemoinformaics analysis of (2S) Naringenin 7-O-?-glucopiranoside
Molecular Weight | 869.41 | nRot | 48 |
Heavy Atom Molecular Weight | 768.61 | nRig | 7 |
Exact Molecular Weight | 868.752 | nRing | 0 |
Solubility: LogS | -7.864 | nHRing | 0 |
Solubility: LogP | 17.007 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 162 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 62 | No. of Aromatic Carbocycles | 0 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 100 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 56 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 6 | APOL | 165.011 |
nHD | 0 | BPOL | 108.133 |
QED | 0.026 |
Synth | 3.692 |
Natural Product Likeliness | 0.563 |
NR-PPAR-gamma | 0.057 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.65 |
HIA | 0.013 |
CACO-2 | -4.938 |
MDCK | 0.00000351 |
BBB | 0 |
PPB | 1.13903 |
VDSS | 4.044 |
FU | 0.0056915 |
CYP1A2-inh | 0.013 |
CYP1A2-sub | 0.064 |
CYP2c19-inh | 0.064 |
CYP2c19-sub | 0.022 |
CYP2c9-inh | 0.016 |
CYP2c9-sub | 0.989 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.006 |
CYP3a4-inh | 0.165 |
CYP3a4-sub | 0.006 |
CL | 4.933 |
T12 | 0.006 |
hERG | 0.122 |
Ames | 0.009 |
ROA | 0 |
SkinSen | 0.998 |
Carcinogencity | 0.159 |
EI | 0.785 |
Respiratory | 0.117 |
NR-Aromatase | 0.067 |
Antiviral | Yes |
Prediction | 0.74376 |